Innophos Holdings, Inc. (NASDAQ:IPHS) has earned a consensus broker rating score of 2.33 (Buy) from the three brokers that cover the stock, Zacks Investment Research reports. Two research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. Innophos Holdings’ rating score has improved by 22.3% in the last 90 days as a result of various analysts’ upgrades and downgrades.

Brokerages have set a 1-year consensus target price of $49.50 for the company and are anticipating that the company will post $0.52 earnings per share for the current quarter, according to Zacks. Zacks has also given Innophos Holdings an industry rank of 33 out of 265 based on the ratings given to related companies.

Several research firms recently commented on IPHS. Zacks Investment Research upgraded Innophos Holdings from a “sell” rating to a “hold” rating in a report on Tuesday. Sidoti raised Innophos Holdings from a “neutral” rating to a “buy” rating in a research report on Friday, May 26th. They noted that the move was a valuation call.

COPYRIGHT VIOLATION NOTICE: This article was originally published by American Banking News and is the property of of American Banking News. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://www.americanbankingnews.com/2017/07/12/analysts-anticipate-innophos-holdings-inc-iphs-to-announce-0-52-earnings-per-share.html.

Several institutional investors have recently added to or reduced their stakes in the stock. American Century Companies Inc. increased its position in Innophos Holdings by 30.4% in the first quarter. American Century Companies Inc. now owns 362,850 shares of the specialty chemicals company’s stock valued at $19,583,000 after buying an additional 84,542 shares in the last quarter. Great West Life Assurance Co. Can increased its position in Innophos Holdings by 5.7% in the first quarter. Great West Life Assurance Co. Can now owns 26,926 shares of the specialty chemicals company’s stock valued at $1,452,000 after buying an additional 1,447 shares in the last quarter. Personal Capital Advisors Corp increased its position in Innophos Holdings by 9.6% in the first quarter. Personal Capital Advisors Corp now owns 110,646 shares of the specialty chemicals company’s stock valued at $5,939,000 after buying an additional 9,717 shares in the last quarter. State of Alaska Department of Revenue increased its position in Innophos Holdings by 81.4% in the first quarter. State of Alaska Department of Revenue now owns 3,810 shares of the specialty chemicals company’s stock valued at $205,000 after buying an additional 1,710 shares in the last quarter. Finally, Louisiana State Employees Retirement System increased its position in Innophos Holdings by 1.3% in the first quarter. Louisiana State Employees Retirement System now owns 7,900 shares of the specialty chemicals company’s stock valued at $426,000 after buying an additional 100 shares in the last quarter. 94.55% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Innophos Holdings (NASDAQ IPHS) traded up 0.570% on Wednesday, hitting $43.225. 71,587 shares of the stock were exchanged. The company has a market cap of $837.53 million, a price-to-earnings ratio of 18.552 and a beta of 0.86. The company has a 50 day moving average of $43.81 and a 200 day moving average of $48.83. Innophos Holdings has a 52-week low of $37.02 and a 52-week high of $58.22.

Innophos Holdings (NASDAQ:IPHS) last announced its quarterly earnings data on Monday, May 1st. The specialty chemicals company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.52 by $0.07. The business had revenue of $165.94 million during the quarter, compared to analyst estimates of $168.11 million. Innophos Holdings had a return on equity of 14.11% and a net margin of 6.56%. The company’s revenue for the quarter was down 12.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.66 earnings per share. Equities research analysts forecast that Innophos Holdings will post $2.49 earnings per share for the current year.

Innophos Holdings Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Get a free copy of the Zacks research report on Innophos Holdings (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.